Lipoxin and resolvin biosynthesis is dependent on 5‐lipoxygenase activating protein

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The FASEB Journal

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1096/fj.15-275487PMID 26289316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mammalian lipoxygenases and their biological relevance.

  2015cited by this paper
• PENG: A Neural Gas-Based Approach for Pharmacophore Elucidation. Method Design, Validation, and Virtual Screening for Novel Ligands of LTA4H

  2015cited by this paper
• Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway

  2014cited by this paper
• Roles of coactosin-like protein (CLP) and 5-lipoxygenase-activating protein (FLAP) in cellular leukotriene biosynthesis

  2014cited by this paper
• Chiral chromatography-tandem mass spectrometry applied to the determination of pro-resolving lipid mediators.

  2014cited by this paper
• Stabilisation and characterisation of the isolated regulatory domain of human 5-lipoxygenase.

  2014cited by this paper
• Phospholipase A2 regulates eicosanoid class switching during inflammasome activation

  2014cited by this paper
• Resolvin D1 and its GPCRs in resolution circuits of inflammation.

  2013cited by this paper
• Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators

  2013cited by this paper
• Synthesis of Lipid Mediators during UVB-Induced Inflammatory Hyperalgesia in Rats and Mice

  2013cited by this paper
• Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness.

  2010cited by this paper
• Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis.

  2010cited by this paper
• Lipoxin and Aspirin-Triggered Lipoxins

  2010cited by this paper
• 5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity

  2010cited by this paper
• Resolvins and protectins: natural pharmacophores for resolution biology.

  2010cited by this paper
• MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregation.

  2009cited by this paper
• Development of a method for expression and purification of the regulatory C2-like domain of human 5-lipoxygenase.

  2008cited by this paper
• Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

  2008influential reference
• 5-Lipoxygenase–Activating Protein: A Potential Link Between Innate and Adaptive Immunity in Atherosclerosis and Adipose Tissue Inflammation

  2007cited by this paper
• Anti-Inflammatory Activity of a Potent, Selective Leukotriene A4 Hydrolase Inhibitor in Comparison with the 5-Lipoxygenase Inhibitor Zileuton

  2007cited by this paper
• Resolvin D1 and Its Aspirin-triggered 17R Epimer

  2007cited by this paper
• ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance

  2006cited by this paper
• Resolution of in flammation: state of the art, definitions and terms

  2006cited by this paper
• 1-Oleoyl-2-acetylglycerol Stimulates 5-Lipoxygenase Activity via a Putative (Phospho)lipid Binding Site within the N-terminal C2-like Domain*

  2005cited by this paper
• The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm

  2004cited by this paper
• Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes.

  2002cited by this paper
• Molecular Basis of the Specific Subcellular Localization of the C2-like Domain of 5-Lipoxygenase*

  2002cited by this paper
• Cellular Oxygenation of 12-Hydroxyeicosatetraenoic Acid and 15-Hydroxyeicosatetraenoic Acid by 5-Lipoxygenase Is Stimulated by 5-Lipoxygenase-activating Protein*

  1998cited by this paper
• 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors

  1996cited by this paper
• The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action.

  1996cited by this paper
• Purification of transforming growth factor beta 1 from human platelets.

  1996cited by this paper
• Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3.

  1995cited by this paper
• Structural requirements for the binding of fatty acids to 5-lipoxygenase-activating protein.

  1994influential reference
• Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins.

  1993cited by this paper
• Lipoxin synthase activity of human platelet 12-lipoxygenase.

  1993cited by this paper
• 5‐lipoxygenase‐activating protein is an arachidonate binding protein

  1993cited by this paper
• 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase.

  1993cited by this paper
• Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations.

  1992cited by this paper
• Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids.

  1990cited by this paper
• Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro.

  1990cited by this paper
• MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes.

  1990cited by this paper
• Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils

  1990cited by this paper
• Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. A potential cellular source of leukotriene C4.

  1988cited by this paper
• Novel transcellular interaction: conversion of granulocyte-derived leukotriene A4 to cysteinyl-containing leukotrienes by human platelets.

  1988cited by this paper
• Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human platelet-granulocyte suspensions.

  1988cited by this paper

• Leukocyte-type 12/15-lipoxygenase is essential for timely inflammation-resolution and effective tissue regeneration following skeletal muscle injury

  2025cites this paper
• Leukotriene B4 regulates T cell recognition and control of MCMV in mucosal tissues

  2025cites this paper
• Control of ALOX5 expression in monocytic cells using a synthetic riboswitch.

  2025cites this paper
• Exacerbation of atherosclerosis, hyperlipidemia and inflammation by MK886, an inhibitor of leukotriene biosynthesis, in obese and diabetic mice

  2024cites this paper
• Of rodents, research and relationships: a pharmacological odyssey

  2024cites this paper
• Resolving neutrophils through genetic deletion of TRAM attenuate atherosclerosis pathogenesis

  2024cites this paper
• Murine Alox8 versus the human ALOX15B ortholog: differences and similarities

  2024cites this paper
• The role of human 5-Lipoxygenase (5-LO) in carcinogenesis - a question of canonical and non-canonical functions

  2024cites this paper
• Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer

  2024cites this paper
• Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair

  2023cites this paper
• Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators

  2023cites this paper
• Formation of Lipoxins and Resolvins in Human Leukocytes.

  2023cites this paper
• Investigating the catalytic efficiency of C22-Fatty acids with LOX human isozymes and the platelet response of the C22-oxylipin products.

  2023cites this paper
• Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators

  2023influential citation
• Polyunsaturated Fatty Acid-Derived Lipid Mediators as Potential Biomarkers for Leprosy Among Individuals with Asymptomatic Mycobacterium leprae Infection.

  2023cites this paper
• Aspirin modulates production of pro-inflammatory and pro-resolving mediators in endothelial cells

  2023cites this paper
• Effects of Atherogenic Factors on Endothelial Cells: Bioinformatics Analysis of Differentially Expressed Genes and Signaling Pathways

  2023cites this paper
• Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis

  2022cites this paper
• Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology

  2022cites this paper
• Neutrophils in Intestinal Inflammation: What We Know and What We Could Expect for the Near Future

  2022cites this paper
• Formation of eicosanoids and other oxylipins in human macrophages.

  2022cites this paper
• Gut Microbiota Alter Visceral Pain Sensation and Inflammation via Modulation of Synthesis of Resolvin D1 in Colonic Tuft Cells.

  2022cites this paper
• CF Patients’ Airway Epithelium and Sex Contribute to Biosynthesis Defects of Pro-Resolving Lipids

  2022influential citation
• Molecular Pharmacology of Inflammation Resolution in Atherosclerosis

  2022cites this paper
• Modulatory Effects of Mushrooms on the Inflammatory Signaling Pathways and Pro-inflammatory Mediators

  2022cites this paper
• Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

  2022influential citation
• Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201

  2022cites this paper
• Development and in vitro Profiling of Dual FXR/LTA4H Modulators

  2021cites this paper
• On the biosynthesis of specialized pro-resolving mediators in human neutrophils and the influence of cell integrity.

  2021cites this paper
• Lipids as regulators of inflammation and tissue regeneration

  2021cites this paper
• Atherosclerosis is a Major Human Killer and Non-resolving Inflammation is a Prime Suspect.

  2021influential citation
• The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis

  2021cites this paper
• Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: the battle between pro- and anti-inflammatory lipid mediators.

  2021cites this paper
• Resolvin D1 protects against cadmium chloride-induced memory loss and hippocampal damage in rats: A comparison with docosahexaenoic acid

  2021influential citation
• Determination of inflammation-related lipids in depressive rats by on-line supercritical fluid extraction-supercritical fluid chromatography-tandem mass spectrometry.

  2021cites this paper
• Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases

  2021cites this paper
• Cellular Responses to the Efferocytosis of Apoptotic Cells

  2021cites this paper
• Developments of specialized pro-resolving mediators in periodontitis.

  2021cites this paper
• Spinal neuronal excitability and neuroinflammation in a model of chemotherapeutic neuropathic pain: targeting the resolution pathways

  2020cites this paper
• Metabolomics Analysis of Laparoscopic Surgery Combined with Wuda Granule to Promote Rapid Recovery of Patients with Colorectal Cancer Using UPLC/Q-TOF-MS/MS

  2020cites this paper
• Long-term stimulation of toll-like receptor-2 and -4 upregulates 5-LO and 15-LO-2 expression thereby inducing a lipid mediator shift in human monocyte-derived macrophages.

  2020cites this paper
• Dietary polyacetylene falcarinol upregulated intestinal heme oxygenase-1 and modified plasma cytokine profile in late phase lipopolysaccharide-induced acute inflammation in CB57BL/6 mice.

  2020cites this paper
• Extracellular vesicles of MSCs and cardiomyoblasts are vehicles for lipid mediators.

  2020cites this paper
• Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators

  2020cites this paper
• Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples

  2019cites this paper
• Redox (phospho)lipidomics of signaling in inflammation and programmed cell death

  2019cites this paper
• Biosynthesis, Biological Functions, and Receptors of Leukotriene B4 and 12(S)-Hydroxyheptadecatrienoic Acid

  2019cites this paper
• Beyond leukotriene formation-The noncanonical functions of 5-lipoxygenase.

  2019cites this paper
• Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome

  2019cites this paper
• Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution.

  2018cites this paper
• Two‐pronged approach to anti‐inflammatory therapy through the modulation of the arachidonic acid cascade

  2018cites this paper
• Leukotriene biosynthetic enzymes as therapeutic targets.

  2018cites this paper
• Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis.

  2018cites this paper
• Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway

  2017cites this paper
• A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in mice.

  2017cites this paper
• Roles of Specialized Proresolving Lipid Mediators in Inflammation Resolution and Tissue Repair

  2017cites this paper
• Eicosanoids and exosomes : a link between macrophages and lung cancer

  2017cites this paper
• PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo

  2017cites this paper
• Boosting Inflammation Resolution in Atherosclerosis

  2017influential citation
• Distinct differences in serum eicosanoids in healthy, enteritis and colorectal cancer individuals

  2017cites this paper
• Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening

  2017cites this paper
• Pro-resolution therapeutics for cardiovascular diseases.

  2017cites this paper
• Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis.

  2017cites this paper
• Mammalian ALOX15 orthologs exhibit pronounced dual positional specificity with docosahexaenoic acid.

  2017cites this paper
• Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents

  2017cites this paper
• Serum polyunsaturated fatty acid metabolites as useful tool for screening potential biomarker of colorectal cancer.

  2017cites this paper
• GM‐CSF– and M‐CSF–primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures

  2017cites this paper
• Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain

  2017cites this paper
• Characterization of the molecular mechanism of 5‐lipoxygenase inhibition by 2‐aminothiazoles

  2017cites this paper
• Biosynthesis of leukotriene B4.

  2017cites this paper
• Pro-resolving actions of SPM in adipose tissue biology.

  2017cites this paper
• Characterization and cellular localization of human 5-lipoxygenase and its protein isoforms 5-LOΔ13, 5-LOΔ4 and 5-LOp12.

  2017cites this paper
• Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.

  2017cites this paper
• Identification and Characterization of a New Protein Isoform of Human 5-Lipoxygenase

  2016cites this paper
• Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase

  2016cites this paper
• The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis

  2016cites this paper
• Thermodynamic properties of leukotriene A4 hydrolase inhibitors.

  2016cites this paper
• An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

  2016cites this paper
• Fine-tuning inflammation-resolution programs: focus on atherosclerosis

  2016cites this paper
• Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome[S]

  2016cites this paper
• The role of FPR2/ALX in the vascular wall

  2015cites this paper